MetaCap

Capstone (CAPS) vs Eocene (EOCN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Eocene is the larger company by market cap ($3.9 million vs $3.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

CAPS versus EOCN key metrics
MetricCAPSEOCN
Share price$0.1409$3.62
Market cap$3.72M$3.87M
1-day change+0.57%+4.69%
EPS (TTM)$-3.32$-15.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.36$12.88
52-week low$0.1339$3.12
Distance from 52-week high-89.64%-71.89%
Average volume4.35M59.65K
Shares outstanding26.38M1.07M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

CAPS vs EOCN FAQ

Which is bigger, Capstone or Eocene?

Eocene (EOCN) is larger, with a market capitalization of $3.87M compared with $3.72M for Capstone (CAPS).

Are Capstone and Eocene in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons